As of 2025, we are thrilled to announce the launch of our new PROVE Study Group, dedicated to Patient-Centered & Real-World Evaluation of Image-Guided Interventions and AI.
The pace of innovation in imaging and image-guided treatments is accelerating, and the window for evaluation is narrow. With Artificial Intelligence further speeding up this innovation, solid clinical evidence is crucial. This ensures that effective innovations quickly become part of routine care while preventing the adoption of those that don’t benefit patients. Together with HM (Lenny) Verkooijen, Sofie Gernaat, and Roxanne Gal, we have combined our strengths to learn deeply from every patient. Our goal is to facilitate the evaluation and evidence-based implementation of innovations using large, real-world patient populations.
The PROVE Study Group is committed to providing the necessary knowledge, expertise, skills, and data infrastructure. This ensures that the development of image-guided innovations and AI is focused where it is needed most. We aim to generate robust scientific evidence on the (cost-)effectiveness of these technologies to support their rapid, evidence-based implementation.
Check out our team and projects on our new website: https://lnkd.in/exZQ5iga
Stay tuned for more updates and exciting developments from the PROVE Study Group!
